NDC 55289-443

Benicar HCT

Olmesartan Medoxomil-hydrochlorothiazide

Benicar HCT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Olmesartan Medoxomil; Hydrochlorothiazide.

Product ID55289-443_7c4889dd-2a20-f1ec-e053-2991aa0a0e0c
NDC55289-443
Product TypeHuman Prescription Drug
Proprietary NameBenicar HCT
Generic NameOlmesartan Medoxomil-hydrochlorothiazide
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2003-06-05
Marketing CategoryNDA / NDA
Application NumberNDA021532
Labeler NamePD-Rx Pharmaceuticals, Inc.
Substance NameOLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE
Active Ingredient Strength40 mg/1; mg/1
Pharm ClassesAngiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 55289-443-30

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-443-30)
Marketing Start Date2012-05-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55289-443-30 [55289044330]

Benicar HCT TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021532
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-05-04
Marketing End Date2019-09-12

Drug Details

Active Ingredients

IngredientStrength
OLMESARTAN MEDOXOMIL40 mg/1

OpenFDA Data

SPL SET ID:91d45442-4232-4111-9dd8-0d787085af6d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 847042
  • 403855
  • UPC Code
  • 0355289443308
  • Pharmacological Class

    • Angiotensin 2 Receptor Antagonists [MoA]
    • Angiotensin 2 Receptor Blocker [EPC]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "Benicar HCT" or generic name "Olmesartan Medoxomil-hydrochlorothiazide"

    NDCBrand NameGeneric Name
    0713-0863Benicar HCTolmesartan medoxomil-hydrochlorothiazide
    0713-0864Benicar HCTolmesartan medoxomil-hydrochlorothiazide
    0713-0865Benicar HCTolmesartan medoxomil-hydrochlorothiazide
    50090-1083Benicar HCTolmesartan medoxomil-hydrochlorothiazide
    55289-443Benicar HCTolmesartan medoxomil-hydrochlorothiazide
    65597-105Benicar HCTolmesartan medoxomil-hydrochlorothiazide
    65597-106Benicar HCTolmesartan medoxomil-hydrochlorothiazide
    65597-107Benicar HCTolmesartan medoxomil-hydrochlorothiazide
    50090-4329Olmesartan Medoxomil and Hydrochlorothiazideolmesartan medoxomil-hydrochlorothiazide
    57664-758Olmesartan Medoxomil and Hydrochlorothiazideolmesartan medoxomil-hydrochlorothiazide
    57664-759Olmesartan Medoxomil and Hydrochlorothiazideolmesartan medoxomil-hydrochlorothiazide
    57664-760Olmesartan Medoxomil and Hydrochlorothiazideolmesartan medoxomil-hydrochlorothiazide
    71335-0203Olmesartan Medoxomil and Hydrochlorothiazideolmesartan medoxomil-hydrochlorothiazide

    Trademark Results [Benicar HCT]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    BENICAR HCT
    BENICAR HCT
    78323613 2928799 Live/Registered
    DAIICHI SANKYO COMPANY, LIMITED
    2003-11-05
    BENICAR HCT
    BENICAR HCT
    78308053 not registered Dead/Abandoned
    SANKYO COMPANY LIMITED
    2003-10-01
    BENICAR HCT
    BENICAR HCT
    78138481 2867773 Live/Registered
    DAIICHI SANKYO COMPANY, LIMITED
    2002-06-25

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.